Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Spirits up as Prosonix gets Down for CMO

This article was originally published in Scrip

Executive Summary

Respiratory medicines developer Prosonix has appointed Dr Geoff Down to the newly created role of chief medical officer. Dr Down has over 18 years' clinical development experience in pharma, following 10 years in clinical practice. He joins Prosonix having most recently run his own company providing services as a consultant pharmaceutical physician, during which time he worked in clinical safety for Pfizer R&D, in clinical development for RespiVert, and in clinical pharmacology at GlaxoSmithKline's R&D Respiratory and Immuno-Inflammation medicines development centre.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts